Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.13 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.358NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.358NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.28NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
B.1.177.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.60NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.159NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.141NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.141NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.591NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.591NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.468NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.468NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.131 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.131 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.586NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.586NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.424NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.61NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.264NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.581NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.581NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.330NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.330NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
B.1.495NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.495NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.294NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.453NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.453NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.44NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.350NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.350NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.304NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.304NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.315NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.315NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.516NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.354NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used